NCCN Working with Medlive to Advance High-Quality Cancer Care in China and Worldwide
PR98539
PLYMOUTH MEETING, Pa., Nov. 2, 2022 /PRNewswire=KYODO JBN/ --
--United States-based National Comprehensive Cancer Network enters strategic
cooperation agreement with Chinese medical information website to publish and
translate evidence-based expert consensus guidelines for cancer care; now
available at nccnchina.org.cn (
).
The National Comprehensive Cancer Network(R) (NCCN (
https://c212.net/c/link/?t=0&l=en&o=3691705-1&h=769424173&u=http%3A%2F%2Fwww.nccn.org%2F&a=NCCN
)(R))-an alliance of leading cancer centers (
) in the United States-is announcing a new collaboration with Medlive to share
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines(R) (
) in China at nccnchina.org.cn (
). NCCN Guidelines(R) are the recognized standard for clinical direction and
policy in cancer management and the most thorough and frequently-updated
clinical practice guidelines available in any area of medicine.
Logo - https://mma.prnewswire.com/media/441768/NCCN_Logo.jpg
The current library of 84 evidence-based, expert consensus practice guidelines
cover 97% of cancer cases affecting patients-with specific treatment
recommendations for nearly every type of cancer, plus supportive care and
prevention-and are updated at least once-a-year. There are also 65
patient-focused versions of the guidelines for patients and caregivers. All are
now available at quicker in-country download speeds with a one-step
registration process, also via guide.medlive.cn/NCCN (
) on computer or the Medlive APP on smartphone. These resources will also be
translated into Chinese in the future.
"We are committed to making sure providers and patients have access to the most
up-to-date standards in cancer care around the world," said Robert W. Carlson,
MD, Chief Executive Officer, NCCN. "At NCCN, we believe that everyone worldwide
should benefit from the rapidly expanding knowledge on how to treat cancer most
effectively; and we work tirelessly to make that happen. We are proud to
collaborate with Medlive on this important project."
Although NCCN is a U.S.-based organization, NCCN resources are accessed and
utilized throughout the world. Nearly half of the 1.5 million registered users
viewing NCCN Guidelines at NCCN.org (
) or via the Virtual Library of NCCN Guidelines(R) app (
) are located outside of the U.S. China is currently the third-highest country
for clinical practice guideline downloads, with more than 400,000 per year.
This new in-country platform for guidelines is expected to increase that number
significantly.
"We are happy to introduce a new home for NCCN resources in China here on our
Medlive platform, providing doctors with faster access to NCCN Guidelines,"
said Tian Lixin, President, Medlive. "This collaboration will help oncologists
in China to reference the widely-recognized NCCN Guidelines, so all patients
can receive high-quality, effective, and efficient treatment according to the
latest evidence-based expert consensus standards."
"Both NCCN and Medlive recognize the importance of collaboration and mutual
learning," said Xin Jiangtao, Vice President, Medlive. "We are pleased to use
this platform for knowledge sharing between oncology circles in Asia and the
United States, ultimately improving care for patients everywhere."
The collaboration will focus on providing the full English-language library of
NCCN Guidelines on Medlive's platform (in addition to their longtime home at
NCCN.org (
)), with Chinese translations to follow in the near future. The new website
specifically for NCCN on Medlive was first announced on June 15, 2022 with a
live conference hosted by Medlive. The full broadcast is available on-demand at
class.medlive.cn/class/live/close/68550 (
).
Visit NCCN.org/global (
) to learn more about NCCN's work to improve cancer outcomes around the world.
Join the conversation online with the hashtag #NCCNGlobal (
).
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network(R) (NCCN (
https://c212.net/c/link/?t=0&l=en&o=3691705-1&h=769424173&u=http%3A%2F%2Fwww.nccn.org%2F&a=NCCN
)(R)) is a not-for-profit alliance of leading cancer centers (
) devoted to patient care, research, and education. NCCN is dedicated to
improving and facilitating quality, effective, equitable, and accessible cancer
care so all patients can live better lives. The NCCN Clinical Practice
Guidelines in Oncology (NCCN Guidelines (
)(R)) provide transparent, evidence-based, expert consensus recommendations for
cancer treatment, prevention, and supportive services; they are the recognized
standard for clinical direction and policy in cancer management and the most
thorough and frequently-updated clinical practice guidelines available in any
area of medicine. The NCCN Guidelines for Patients (
)(R) provide expert cancer treatment information to inform and empower patients
and caregivers, through support from the NCCN Foundation (
)(R). NCCN also advances continuing education (
), global initiatives (
), policy (
), and research collaboration (
) and publication(
) in oncology. Visit NCCN.org (
https://c212.net/c/link/?t=0&l=en&o=3691705-1&h=3324630050&u=http%3A%2F%2Fwww.nccn.org%2F&a=NCCN.org
) for more information and follow NCCN on Facebook @NCCNorg (
), Instagram @NCCNorg (
), and Twitter @NCCN (
).
Media Contact:
Rachel Darwin
267-622-6624
darwin@nccn.org
SOURCE: National Comprehensive Cancer Network
本プレスリリースは発表元が入力した原稿をそのまま掲載しております。また、プレスリリースへのお問い合わせは発表元に直接お願いいたします。
このプレスリリースには、報道機関向けの情報があります。
プレス会員登録を行うと、広報担当者の連絡先や、イベント・記者会見の情報など、報道機関だけに公開する情報が閲覧できるようになります。
